Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 04 Dec 2023

Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib

in Hematologic Malignancies

Baustin M. Welch
Bryce A. Manso
Kimberly A. Gwin
Petra K. Lothert
Sameer A. Parikh
Neil E. Kay
Kay L. Medina

Frontiers in Oncology

doi 10.3389/fonc.2023.1302038

2,965 views
2 citations

Original Research

Published on 04 Dec 2023

Quantitative Dixon and intravoxel incoherent motion diffusion magnetic resonance imaging parameters in lumbar vertebrae for differentiating aplastic anemia and acute myeloid leukemia

in Hematologic Malignancies

Meidan Hou
Yanan Huang
Jinsong Yan
Guoguang Fan

Frontiers in Oncology

doi 10.3389/fonc.2023.1277978

2,511 views
3 citations

Editorial

Published on 01 Dec 2023

Editorial: Deciphering and targeting the mTOR pathway in hematologic malignancies

in Hematologic Malignancies

Luca Lo Nigro

Frontiers in Oncology

doi 10.3389/fonc.2023.1293795

1,454 views

Original Research

Published on 01 Dec 2023

Systemic immunological profile of children with B-cell acute lymphoblastic leukemia: performance of cell populations and soluble mediators as serum biomarkers

in Hematologic Malignancies

Maria Perpétuo Socorro Sampaio Carvalho
Fábio Magalhães-Gama
Bruna Pires Loiola
Juliana Costa Ferreira Neves
Nilberto Dias Araújo
Flavio Souza Silva
Claudio Lucas Santos Catão
Eliana Brasil Alves
João Paulo Diniz Pimentel
Maria Nazaré Saunier Barbosa

Frontiers in Oncology

doi 10.3389/fonc.2023.1290505

5,571 views
4 citations

Case Report

Published on 01 Dec 2023

Case Report: Identification of a novel LYN::LINC01900 transcript with promyelocytic phenotype and TP53 mutation in acute myeloid leukemia

in Hematologic Malignancies

Chengjun Hu
Qiuxin Dai
Ruiyi Zhang
Huanping Yang
Man Wang
Kaili Gu
Jiangang Yang
Wenjun Meng
Ping Chen
Maozhong Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1322403

6,082 views
2 citations

Original Research

Published on 30 Nov 2023

Pulmonary infection associated with immune dysfunction is associated with poor prognosis in patients with myelodysplastic syndrome accompanied by TP53 abnormalities

in Hematologic Malignancies

Yi Chen
Jing Zheng
Yanyan Qiu
Zhengjun Wu
Xiaofeng Luo
Liangfang Zhu
Yong Wu
Yanjuan Lin

Frontiers in Oncology

doi 10.3389/fonc.2023.1294037

2,671 views

Original Research

Published on 30 Nov 2023

Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia

in Hematologic Malignancies

Peng Ke
Jundan Xie
Ting Xu
Meiyu Chen
Yusha Guo
Ying Wang
Huiying Qiu
Depei Wu
Zhao Zeng
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1302356

4,274 views
4 citations

Case Report

Published on 30 Nov 2023

Treatment for a primary multidrug-resistant B-cell acute lymphoblastic leukemia patient carrying a SSBP2-CSF1R fusion gene: a case report

in Hematologic Malignancies

Huan Wang
Yujiao Wang
Liangchun Hao
Xuan Liu
Jihong Zhang
Pin Yao
Danping Liu
Runan Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1291570

2,713 views
2 citations

Original Research

Published on 30 Nov 2023

Patient-reported symptoms and diagnostic journey in Multiple Myeloma

in Hematologic Malignancies

Rohit Vijjhalwar
Kaiyang Song
Roshi Shrestha
Stella Bowcock
Maria T. Sanchez-Santos
Karthik Ramasamy
Muhammad Kassim Javaid

Frontiers in Oncology

doi 10.3389/fonc.2023.1282569

4,582 views
2 citations

Case Report

Published on 28 Nov 2023

Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review

in Hematologic Malignancies

Jiajie He
Rui Zou
Liqing Kang
Lingzi Yu
Peng Wang
Yang Shao
Junheng Liang
Depei Wu
Zhengming Jin
Changju Qu

Frontiers in Oncology

doi 10.3389/fonc.2023.1283194

3,282 views
2 citations

Original Research

Published on 28 Nov 2023

Definition of bulky disease in early stage diffuse large B-cell lymphoma in computed tomography on coronal and transverse planes

in Hematologic Malignancies

Mohammad Ma’koseh
Heba Farfoura
Yumna Khatib
Zaid Omari
Hazim Ababneh
Baha A. Fayoumi
Ayat Taqash
Mohammad Al-Rwashdeh
Alaa Abufara
Omar Shahin

Frontiers in Oncology

doi 10.3389/fonc.2023.1063438

6,329 views
4 citations

Original Research

Published on 27 Nov 2023

Hematologic secondary malignancies among 102 Chinese patients with Waldenstrom’s macroglobulinemia: a single-center case experience and literature review

in Hematologic Malignancies

Lingling Wang
Conglin Xi
Yongfen Huang
Hao Xu
Yuqing Miao
Yuexin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1280033

1,966 views
2 citations

Original Research

Published on 23 Nov 2023

Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells

in Hematologic Malignancies

Benigno C. Valdez
Bin Yuan
David Murray
Jeremy Leon Ramdial
Yago Nieto
Uday Popat
Xiaowen Tang
Borje S. Andersson

Frontiers in Oncology

doi 10.3389/fonc.2023.1287444

3,949 views
6 citations

Original Research

Published on 21 Nov 2023

Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

in Hematologic Malignancies

Hang Zhang
Qiang Zeng
Tian Dong
Xinchuan Chen
Pu Kuang
Jian Li
Qiuhui Wu
Ting Liu
Ting Niu
Zhigang Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1280336

2,919 views
1 citation

Mini Review

Published on 17 Nov 2023

CPX-351 in FLT3-mutated acute myeloid leukemia

in Hematologic Malignancies

Claire Andrews
Vinod Pullarkat
Christian Recher

Frontiers in Oncology

doi 10.3389/fonc.2023.1271722

6,281 views
5 citations

Original Research

Published on 16 Nov 2023

The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma

in Hematologic Malignancies

Sang Eun Yoon
Sujin Park
Junhun Cho
Kyung Ju Ryu
Booma Yandava
Sewon Lee
Seok Jin Kim
Won Seog Kim

Frontiers in Oncology

doi 10.3389/fonc.2023.1194315

3,241 views
1 citation

Editorial

Published on 14 Nov 2023

Editorial: Digital health and real-world evidence in onco-hematological patients

in Hematologic Malignancies

Claudia Vener
Laura Lopez-Perez
Maria Fernanda Cabrera-Umpiérrez
Giuseppe Fico

Frontiers in Oncology

doi 10.3389/fonc.2023.1330407

1,469 views

Case Report

Published on 14 Nov 2023

Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment

in Hematologic Malignancies

Franziska Marquard
Claudia Langebrake
Dietlinde Janson
Maida Mahmud
Adrin Dadkhah
Nicolaus Kröger
Francis Ayuk

Frontiers in Oncology

doi 10.3389/fonc.2023.1288764

3,633 views
5 citations

Original Research

Published on 13 Nov 2023

Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients

in Hematologic Malignancies

Modeline N. Longjohn
Jo-Anna B. J. Hudson
Lourdes Peña-Castillo
Robert P. J. Cormier
Brandon Hannay
Simi Chacko
Stephen M. Lewis
Paul C. Moorehead
Sherri L. Christian

Frontiers in Oncology

doi 10.3389/fonc.2023.1272883

4,144 views
3 citations

Review

Published on 08 Nov 2023

The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas

in Hematologic Malignancies

Victor Tomacinschii
Adrian Mosquera Orgueira
Carlos Aliste Santos
Maria Robu
Sanda Buruiana
Maximo Francisco Fraga Rodriguez

Frontiers in Oncology

doi 10.3389/fonc.2023.1275327

9,406 views
4 citations

Original Research

Published on 08 Nov 2023

Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia in vitro

in Hematologic Malignancies

Yi Xu
David J. Baylink
Chien-Shing Chen
Laren Tan
Jeffrey Xiao
Brandon Park
Ismael Valladares
Mark E. Reeves
Huynh Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1286863

3,128 views
1 citation

Original Research

Published on 07 Nov 2023

Dynamic changes in physical function during intensive chemotherapy affect transplant outcomes in older adults with AML

in Hematologic Malignancies

Gi-June Min
Byung-Sik Cho
Daehun Kwag
Sung-Soo Park
Silvia Park
Jae-Ho Yoon
Sung-Eun Lee
Ki-Seong Eom
Yoo-Jin Kim
Seok Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1281782

2,694 views
3 citations

Editorial

Published on 07 Nov 2023

Editorial: Understanding leukemia biology using genome editing techniques

in Hematologic Malignancies

Silvia Jimenez-Morales
Kaushik Banerjee
Nirmalya Saha
Amrita Basu
Kathy L. McGraw

Frontiers in Oncology

doi 10.3389/fonc.2023.1323584

1,931 views
1 citation

Review

Published on 07 Nov 2023

Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges

in Hematologic Malignancies

Federico Scarmozzino
Marco Pizzi
Filippo Pelizzaro
Valentina Angerilli
Angelo Paolo Dei Tos
Francesco Piazza
Edoardo Vincenzo Savarino
Fabiana Zingone
Matteo Fassan

Frontiers in Oncology

doi 10.3389/fonc.2023.1273305

9,241 views
17 citations

2,053 articles

articles

Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib

Quantitative Dixon and intravoxel incoherent motion diffusion magnetic resonance imaging parameters in lumbar vertebrae for differentiating aplastic anemia and acute myeloid leukemia

Editorial: Deciphering and targeting the mTOR pathway in hematologic malignancies

Systemic immunological profile of children with B-cell acute lymphoblastic leukemia: performance of cell populations and soluble mediators as serum biomarkers

Case Report: Identification of a novel LYN::LINC01900 transcript with promyelocytic phenotype and TP53 mutation in acute myeloid leukemia

Pulmonary infection associated with immune dysfunction is associated with poor prognosis in patients with myelodysplastic syndrome accompanied by TP53 abnormalities

Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia

Treatment for a primary multidrug-resistant B-cell acute lymphoblastic leukemia patient carrying a SSBP2-CSF1R fusion gene: a case report

Patient-reported symptoms and diagnostic journey in Multiple Myeloma

Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review

Definition of bulky disease in early stage diffuse large B-cell lymphoma in computed tomography on coronal and transverse planes

Hematologic secondary malignancies among 102 Chinese patients with Waldenstrom’s macroglobulinemia: a single-center case experience and literature review

Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells

Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

CPX-351 in FLT3-mutated acute myeloid leukemia

The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma

Editorial: Digital health and real-world evidence in onco-hematological patients

Case Report: Lymphodepletion followed by CAR-T cell therapy with Idecabtagen vicleucel in a patient with severe renal impairment

Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients

The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas

Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia in vitro

Dynamic changes in physical function during intensive chemotherapy affect transplant outcomes in older adults with AML

Editorial: Understanding leukemia biology using genome editing techniques

Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges